Abstract
The United Kingdom Prospective Diabetes Study (UKPDS) showed that intensive treatment (ie, glucose-lowering drugs, with a goal fasting blood glucose level of 108 mg/dL) decreases the microvascular complications of type 2 diabetes mellitus. We summarize the key study results and their implications for clinical management of type 2 diabetes mellitus.
Original language | English |
---|---|
Pages (from-to) | 247-253 |
Number of pages | 7 |
Journal | Cleveland Clinic journal of medicine |
Volume | 66 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1999 |